flutamide has been researched along with Lung Diseases, Interstitial in 3 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We gathered cases diagnosed with prostate cancer based on the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database from 2004 to 2020." | 1.91 | Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System. ( Chen, C; Li, J; Shen, P; Wu, B; Wu, F; Xu, T; Yin, X; Yu, L, 2023) |
| "A 88-year-old man with prostate cancer was receiving non-steroidal anti-androgen therapy (flutamide, 375 mg/day)." | 1.32 | Interstitial pneumonitis related to flutamide monotherapy for prostate cancer. ( Fujimoto, N; Matsumoto, T; Nomura, M; Sato, H, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, B | 1 |
| Shen, P | 1 |
| Yin, X | 1 |
| Yu, L | 1 |
| Wu, F | 1 |
| Chen, C | 1 |
| Li, J | 1 |
| Xu, T | 1 |
| Nomura, M | 1 |
| Sato, H | 1 |
| Fujimoto, N | 1 |
| Matsumoto, T | 1 |
| Azuma, T | 1 |
| Kurimoto, S | 1 |
| Mikami, K | 1 |
| Oshi, M | 1 |
3 other studies available for flutamide and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Androgen Antagonists; Antineoplastic Agents, Hormonal; Flut | 2023 |
Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Flutamide; Humans; Lung Di | 2004 |
Interstitial pneumonitis related to leuprorelin acetate and flutamide.
Topics: Aged; Antineoplastic Agents, Hormonal; Flutamide; Humans; Leuprolide; Lung Diseases, Interstitial; M | 1999 |